SCHEMBL2816645

SCHEMBL2816645

Cc1c(F)cc(NC(=O)Nc2[nH]c(CCC(=O)Nc3ccc4[nH]nnc4c3)nc2C(N)=O)c(F)c1F

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.38
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35
NTRK1 P04629 4/20 0.35
NTRK2 Q16620 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MEN1 O00255 1/20 0.34
POLB P06746 1/20 0.34
HTT P42858 1/20 0.34
KMT2A Q03164 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
MAPT P10636 3/20 0.33
USP2 O75604 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
RECQL P46063 1/20 0.33
TNKS O95271 2/20 0.32
MCHR1 Q99705 1/20 0.32
PARP1 P09874 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2813667 0.84 ALDH1A1 (0.41) ALDH1A1CYP1A2CYP3A4CYP2C19SMN1; SMN2
SCHEMBL2814887 0.83 MAPT (0.41) ALDH1A1CYP1A2CYP3A4CYP2C19NTRK1
SCHEMBL2813663 0.83 MCHR1 (0.45) ALDH1A1NTRK1NTRK2MCHR1
SCHEMBL13133024 0.81 ALDH1A1 (0.40) ALDH1A1CYP1A2CYP3A4CYP2C19SMN1; SMN2
SCHEMBL2814846 0.79 PARP1 (0.46) ALDH1A1CYP1A2CYP3A4CYP2C19SMN1; SMN2
SCHEMBL13133022 0.79 PARP1 (0.41) ALDH1A1NTRK1NTRK2MEN1POLB
SCHEMBL13133028 0.78 MCHR1 (0.42) ALDH1A1NTRK1NTRK2MCHR1PARP1
SCHEMBL13133021 0.77 PARP1 (0.42) ALDH1A1CYP1A2CYP3A4CYP2C19SMN1; SMN2
SCHEMBL17957279 0.75 MCHR1 (0.45) ALDH1A1NTRK1NTRK2MAPTMCHR1
SCHEMBL17957241 0.72 MAPT (0.39) ALDH1A1CYP1A2CYP3A4CYP2C19NTRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100249132-A1 IMIDAZOLE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2010-09-30 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249132-A1 IMIDAZOLE DERIVATIVES SDHA, SDHB, TPD52L2 ALDH1A1 198/4885CYP1A2 287/4885CYP3A4 406/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.